lencana Anda Rentang 52M $54–$93 64% of range Peringkat Analis STRONG BUY 35 analysts Target Harga $96 +23% upside P/E 31.2 ROE 38.5% Margin Laba Bersih 20.1%

DXCM Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03
Harga $78.62
Kapitalisasi Pasar (MRQ) $29.67B
P/E (TTM) 31.2
EPS (TTM) $2.52
Pendapatan (TTM) $4.97B
ROE (TTM) 38.5%
Rentang 52M $54–$93

DXCM Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04
rentang
batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Pemecahan saham 1
Tanggal ex-dividen Pemecahan Tipe
13 Juni 2022 4-for-1 Maju

Tentang DexCom, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.

History

Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.

During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.

Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.

The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.

Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.

The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.

Awards and recognition

In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.

Partnerships

Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7

Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."

In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.

Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.

In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.

The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.

In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.

Venture capital arm

In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorHealth Care industriHealth Care karyawan11.000 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06
Pendapatan$4.66B
2016-12-31 → 2025-12-31
EPS$2.09
2017-12-31 → 2025-12-31
Arus Kas Bebas$1.08B
2016-12-31 → 2025-12-31
Margin bersih20.1%
2018-12-31 → 2025-12-31
Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik Tren 5 Tahun DXCM rata-rata 5T Median Rekan Kesimpulan
P/E (TTM) 31.2rata-rata 5T ≈114.7 ≈114.7 29.4 Nilai wajar
P/S (TTM) 6.0rata-rata 5T ≈9.3 ≈9.3 5.0 Terlalu mahal
P/B (MRQ) 11.3rata-rata 5T ≈14.6 ≈14.6 4.6 Terlalu mahal
Harga / FCF (TTM) 21.1rata-rata 5T ≈110.6 ≈110.6 · ·
Harga / Arus Kas (TTM) 17.0rata-rata 5T ≈41.4 ≈41.4 17.7 Nilai wajar
Harga / Nilai Buku Berwujud (MRQ) 11.8rata-rata 5T ≈15.9 ≈15.9 · ·
PEG Ratio (Rasio PEG) ≈3.3 · · ·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14
Kejutan Rata-rata 0.88%
PeriodeLaporanEPS AktualEPS EstimasiKejutan
30 Juni 2026 Jul 28, 2026 $0.70 $0.62 12.4%
31 Maret 2026 $0.56 $0.48 17.0%
31 Des. 2025 $0.45 $0.66 -32.1%
30 Sep. 2025 $0.61 $0.58 5.3%
30 Juni 2025 $0.48 $0.45 6.8%
31 Maret 2025 $0.32 $0.33 -4.1%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15
Laporan Laba Rugi 18
Metrik Tren 202520242023202220212020201920182017201620152014
Revenue $4.66B$4.03B$3.62B$2.91B$2.45B$1.93B$1.48B$1.03B$718M$573M··
Cost of Revenue $1.86B$1.59B$1.33B$1.03B$768M$647M$544M$368M$226M$195M$124M$83M
Gross Profit $2.80B$2.44B$2.29B$1.88B$1.68B$1.28B$932M$664M$492M$378M$278M$176M
R&D Expense $599M$552M$506M$484M$517M$360M$274M$200M$185M$156M$138M$69M
SG&A Expense $1.29B$1.29B$1.19B$1.01B$810M$618M$516M$433M$349M$286M$198M$128M
Operating Expenses $1.89B$1.84B$1.69B$1.49B$1.41B$981M$789M$850M$535M$442M$336M$198M
Operating Income $912M$600M$598M$391M$266M$300M$142M$-186M$-42M$-64M$-57M$-22M
Interest Expense ··$20M$19M$19M$18M$60M$23M$13M$700.0K$400.0K$800.0K
Interest Income ········$3M$400.0K$0$0
Other Non-op $177M$109M$113M$-400.0K$-9M$16M$26M$2M$7M$-700.0K$0$0
Pretax Income $1.09B$709M$710M$391M$257M$298M$104M$-126M$-49M$-65M$-58M$-22M
Income Tax $252M$133M$169M$50M$40M$-252M$3M$600.0K$2M$700.0K$100.0K$100.0K
Net Income $836M$576M$542M$341M$217M$550M$101M$-127M$-50M$-66M$-58M$-22M
EPS (Basic) $2.14$1.46$1.40$0.88$0.56$1.46$1.11$-1.44$-0.58···
EPS (Diluted) $2.09$1.42$1.30$0.82$0.53$1.33$1.10$-1.44$-0.58···
Shares (Basic) 390,200,000393,600,000386,000,000389,400,000386,900,000377,500,00091,100,00088,200,00086,300,000···
Shares (Diluted) 405,500,000412,700,000425,500,000427,500,000428,800,000420,400,00092,300,00088,200,00086,300,000···
EBITDA $1.16B$818M$784M$547M$368M$367M$191M$-157M$-26M$-49M$-46M$-13M
Neraca 26
Metrik Tren 202520242023202220212020201920182017201620152014
Cash & Equivalents $918M$606M$566M$642M$1.05B$818M$446M$1.14B$442M$94M$86M$72M
Short-term Investments ········$93M$23M··
Receivables $1.22B$1.01B$974M$713M$514M$428M$286M$227M$134M$102M$74M$42M
Inventory $629M$543M$560M$307M$357M$235M$120M$71M$45M$45M$35M$16M
Prepaid Expense $189M$174M$168M$193M$82M$54M$30M$16M$17M$9M$7M$4M
Other Current Assets $29M$29M$49M$27M$27M·······
Current Assets $4.03B$4.30B$4.43B$3.67B$3.68B$3.42B$1.97B$1.70B$745M$280M$231M$146M
PP&E (Net) ···$1.06B$802M$515M$321M$183M$146M$109M$55M$31M
PP&E (Gross) ···$1.42B$1.03B$670M$426M$263M$200M$157M$93M$64M
Accum. Depreciation ···$363M$232M$154M$105M$80M$55M$47M$38M$33M
Goodwill $24M$23M$25M$26M$26M$19M$19M$19M$12M$11M$4M$3M
Intangibles $71M$103M$134M$173M$32M····$200.0K$2M$3M
Other Non-current Assets $279M$173M$75M$47M$10M$21M$14M$15M$2M$2M$100.0K$600.0K
Total Assets $6.34B$6.48B$6.26B$5.39B$4.93B$4.29B$2.40B$1.92B$904M$403M$292M$185M
Current Liabilities $2.14B$2.93B$1.56B$1.84B$721M$614M$360M$222M$139M$102M$67M$41M
Capital Leases $73M$65M$80M$95M$99M$102M$72M$0····
Deferred Tax ···$5M$6M$0······
Other Non-current Liabilities $137M$148M$126M$128M$90M$81M$20M$20M$18M$17M$4M$2M
Total Liabilities $3.59B$4.38B$4.20B$3.26B$2.89B$2.46B$1.51B$1.25B$485M$119M$71M$44M
Long-term Debt ···········$5M
Retained Earnings $2.43B$1.60B$1.02B$480M$139M$-78M$-696M$-799M$-672M$-621M$-555M$-498M
Treasury Stock $2.08B$1.58B$2.45B$595M$206M$100M$100M$100M$0···
AOCI $115M$-8M$-17M$-12M$500.0K$3M$2M$2M$-3M$-1M$-300.0K$-100.0K
Stockholders' Equity $2.75B$2.10B$2.07B$2.13B$2.04B$1.55B$883M$663M$419M$284M$221M$140M
Liabilities + Equity $6.34B$6.48B$6.26B$5.39B$4.93B$4.29B$2.40B$1.92B$904M$403M$292M$185M
Shares Outstanding 384,800,000390,700,000385,400,000386,300,000388,000,000384,400,000366,400,00090,000,00087,000,00084,600,00081,700,00077,300,000
Arus Kas 19
Metrik Tren 202520242023202220212020201920182017201620152014
D&A $252M$218M$186M$156M$102M$67M$49M$29M$16M$15M$11M$8M
Stock-based Comp $160M$170M$151M$126M$113M$119M$103M$102M$106M$111M$83M$50M
Deferred Tax $182M$-44M$-55M$-22M$16M$-260M$200.0K$-2M$0$-200.0K$0$0
Amort. of Intangibles $4M$7M$8M$8M$4M$2M···$700.0K$500.0K$600.0K
Restructuring ······$8M·····
Other Non-cash $11M$69M$-75M$68M$77M$73M$62M$122M$20M$-4M$13M$-12M
Operating Cash Flow $1.44B$990M$748M$670M$442M$476M$314M$123M$92M$56M$49M$24M
CapEx $364M$359M$237M$365M$389M$199M$180M$67M$66M$56M$33M$16M
Investing Cash Flow $536M$-208M$-507M$-522M$-216M$-1.02B$-1.02B$-140M$-144M$-56M$-52M$-17M
Debt Issued ···········$0
Net Debt Issued ········$0$-2M$-2M$-2M
Stock Issued $28M$28M$27M$22M$20M$15M$12M$11M$10M$10M$19M$24M
Stock Repurchased $500M$750M$689M$558M$0$0$0$100M$0$0··
Net Stock Activity $-472M$-722M$-662M$-535M$20M$15M$12M$-89M$10M$10M$19M$24M
Financing Cash Flow $-1.69B$-735M$-319M$-552M$10M$912M$11M$710M$399M$8M$17M$22M
Net Change in Cash $312M$40M$-76M$-410M$235M$372M$-691M$696M$347M$8M$14M$29M
Taxes Paid $94M···········
Free Cash Flow $1.08B$631M$512M$305M$53M$277M$134M$56M$26M$500.0K$16M$7M
Levered FCF ··$496M$288M$-36M$91M$76M$33M$13M$-207.6K$15M$7M
Profitabilitas 8
Metrik Tren 202520242023202220212020201920182017201620152014
Gross Margin 60.1%60.5%63.2%64.7%68.6%66.4%63.1%64.4%····
Operating Margin 19.6%14.9%16.5%13.4%10.9%15.5%9.6%-18.1%····
Net Margin 17.9%14.3%14.9%11.7%6.3%25.6%6.9%-12.3%····
Pretax Margin 23.4%17.6%19.6%13.4%7.1%11.7%7.1%-12.3%····
EBITDA Margin 25.0%20.3%21.6%18.8%15.0%19.0%12.9%-15.2%····
ROA 13.0%9.0%9.3%6.6%3.4%14.8%4.7%-9.0%-7.7%-18.9%-24.2%-14.6%
ROE 31.4%28.2%25.0%17.2%7.4%29.7%12.3%-20.7%-14.3%-26.0%-31.9%-20.0%
ROIC 25.5%23.2%22.0%16.0%10.5%36.0%15.6%-28.2%-10.5%-22.8%-25.9%-15.4%
Likuiditas & Solvabilitas 3
Metrik Tren 202520242023202220212020201920182017201620152014
Current Ratio 1.91.52.82.05.15.65.57.65.42.73.53.6
Quick Ratio 1.00.51.00.72.22.02.06.14.82.12.41.8
Interest Coverage ··29.421.02.63.52.4-8.2-3.3-91.3-142.8-26.9
Efisiensi 3
Metrik Tren 202520242023202220212020201920182017201620152014
Asset Turnover 0.70.60.60.60.50.60.70.7····
Inventory Turnover 3.22.93.13.12.63.65.76.35.04.84.86.6
Receivables Turnover 4.24.14.34.75.25.45.85.7····
Per Saham 5
Metrik Tren 202520242023202220212020201920182017201620152014
Book Value / Share $7.14$5.38$5.37$5.52$23.21$19.01$9.64$7.37$4.82$3.35$2.71$1.81
Revenue / Share $11.50$9.77$8.51$6.81$24.46$19.76$15.99·····
Cash Flow / Share $3.55$2.40$1.76$1.57$4.42$4.88$3.41·····
Cash / Share $2.38$1.55$1.47$1.66$10.85$8.51$4.87$12.63$5.07$1.12$1.05$0.93
EPS (TTM) $2.09$1.42$1.30$0.82$0.53$1.33$1.10$-1.44$-0.58···
Tingkat Pertumbuhan 9
Metrik Tren 202520242023202220212020201920182017201620152014
Revenue YoY 15.6%11.3%24.5%18.8%27.1%·······
Revenue CAGR 3Y 17.0%18.1%23.4%·········
Revenue CAGR 5Y 19.3%···········
EPS YoY 47.2%9.2%58.5%54.7%-60.2%·······
EPS CAGR 3Y 36.6%38.9%-0.76%·········
EPS CAGR 5Y 9.5%···········
Net Income YoY 45.1%6.4%58.7%57.3%-60.5%·······
Net Income CAGR 3Y 34.8%38.5%-0.50%·········
Net Income CAGR 5Y 8.8%···········
Valuasi (TTM) 10
Metrik Tren 202520242023202220212020201920182017201620152014
Revenue TTM $4.66B$4.03B$3.62B$2.91B$2.45B$1.93B$1.48B$1.03B$718M$573M$402M$259M
Net Income TTM $836M$576M$542M$341M$217M$550M$101M$-127M$-50M$-66M$-58M$-22M
Market Cap $25.54B$30.38B$47.82B$43.74B$13.02B$8.88B$5.01B$2.70B$1.25B$1.26B$1.67B$1.06B
P/E 31.854.895.5138.1253.369.549.7-20.8-24.7···
P/S 5.57.513.215.05.34.63.42.61.72.24.24.1
P/B 9.314.523.120.55.84.95.74.13.04.47.67.6
P / Tangible Book 9.615.425.122.66.65.8······
P / Cash Flow 17.730.763.965.329.418.715.921.913.622.534.145.1
P / FCF 23.748.293.4143.6244.332.137.248.048.02525.3106.5143.8
Earnings Yield 3.1%1.8%1.1%0.72%0.39%1.4%2.0%-4.8%-4.0%···

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16
Metrik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Pendapatan $4.66B $4.03B $3.62B $2.91B $2.45B
Margin Kotor % 60.1% 60.5% 63.2% 64.7% 68.6%
Margin Operasi % 19.6% 14.9% 16.5% 13.4% 10.9%
Laba Bersih $836M $576M $542M $341M $217M
EPS Dilusian $2.09 $1.42 $1.30 $0.82 $0.53

Pemilik institusional (13F) 1.124 pengaju · $29.8B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 1.124
Nilai yang dipegang $29.8B
Posisi baru 127
Posisi yang keluar 97
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
127 (-41 vs Kuartal sebelumnya) 97 (+5 vs Kuartal sebelumnya) 405 (+35 vs Kuartal sebelumnya) 369 (+18 vs Kuartal sebelumnya) +13.6M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
VANGUARD GROUP INC $3.257.066.468 49.074.378 10,92% Saham
BlackRock, Inc. $2.575.742.626 38.244.137 8,64% Saham
VANGUARD CAPITAL MANAGEMENT LLC $1.697.876.797 25.209.752 5,69% Saham
VANGUARD PORTFOLIO MANAGEMENT LLC $1.323.867.969 19.656.540 4,44% Saham
STATE STREET CORP $1.237.947.284 18.380.806 4,15% Saham
Invesco Ltd. $1.029.655.765 15.288.133 3,45% Saham
BAILLIE GIFFORD & CO $996.887.087 14.801.590 3,34% Saham
GEODE CAPITAL MANAGEMENT, LLC $834.165.910 12.426.515 2,80% Saham
ALLIANCEBERNSTEIN L.P. $734.346.085 11.693.409 2,46% Saham
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $612.059.728 9.746.174 2,05% Saham
WELLINGTON MANAGEMENT GROUP LLP $574.325.172 8.527.471 1,93% Saham
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $462.914.937 6.873.273 1,55% Saham
NORGES BANK $462.565.862 6.868.090 1,55% Saham
UBS Group AG $408.530.217 6.065.779 1,37% Saham
Amundi $377.395.039 5.603.490 1,27% Saham
MORGAN STANLEY $347.275.842 5.156.282 1,16% Saham
AMERIPRISE FINANCIAL INC $324.681.713 4.820.775 1,09% Saham
Castle Hook Partners LP $260.667.534 3.870.342 0,87% Saham
GOLDMAN SACHS GROUP INC $253.142.816 3.758.616 0,85% Saham
FRANKLIN RESOURCES INC $242.183.395 3.595.893 0,81% Saham
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $240.915.152 3.560.621 0,81% Saham
CIBC Bancorp USA Inc. $232.974.509 3.454.735 0,78% Saham
JPMORGAN CHASE & CO $232.690.154 3.325.095 0,78% Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $231.627.696 3.439.164 0,78% Saham
NORTHERN TRUST CORP $221.927.948 3.295.144 0,74% Saham
AQR CAPITAL MANAGEMENT LLC $218.060.428 3.237.720 0,73% Saham
BANK OF AMERICA CORP /DE/ $213.068.756 3.163.604 0,71% Saham
RAYMOND JAMES FINANCIAL INC $207.976.113 3.087.990 0,70% Saham
AMERICAN CENTURY COMPANIES INC $206.860.340 3.071.423 0,69% Saham
CIBC Private Wealth Group LLC $195.665.945 2.907.801 0,66% Saham
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $183.859.102 2.729.905 0,62% Saham
Legal & General Group Plc $173.237.203 2.572.193 0,58% Saham
JANUS HENDERSON GROUP PLC $166.077.317 2.644.539 0,56% Saham
DEUTSCHE BANK AG\ $164.034.901 2.435.559 0,55% Saham
Bank of New York Mellon Corp $155.554.805 2.309.648 0,52% Saham
BNP PARIBAS FINANCIAL MARKETS $152.790.681 2.268.607 0,51% Saham
VANGUARD FIDUCIARY TRUST CO $149.327.006 2.217.179 0,50% Saham
Employees Provident Fund Board $147.498.453 2.190.029 0,49% Saham
DIMENSIONAL FUND ADVISORS LP $142.152.983 2.109.812 0,48% Saham
ROYAL BANK OF CANADA $137.011.000 2.034.290 0,46% Saham
FMR LLC $127.510.091 1.893.246 0,43% Saham
Nuveen, LLC $123.266.328 1.830.235 0,41% Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP $117.263.085 1.741.100 0,39% Opsi jual
NOMURA HOLDINGS INC $115.126.069 1.709.370 0,39% Saham
AXA Investment Managers S.A. $112.203.653 1.667.464 0,38% Saham
BLAIR WILLIAM & CO/IL $112.182.565 1.665.665 0,38% Saham
RENAISSANCE TECHNOLOGIES LLC $109.834.111 1.630.796 0,37% Saham
Swedbank AB $102.218.960 1.184.598 0,34% Saham
VICTORY CAPITAL MANAGEMENT INC $92.130.221 1.367.932 0,31% Saham
DSM CAPITAL PARTNERS LLC $91.537.742 1.359.135 0,31% Saham

Tampilkan semua 1.124 pemilik institusional →

Orang dalam perusahaan 61 orang dalam · 37 pejabat · 26 direktur

19
Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Jacob Steven Leach President, CEO, and Director 22 Agu 2026 F 418.908 2 0 $1.001.761
Andrew P Rasdal President & CEO 2 Mei 2006 M 2.944 0 0 $0
Jess Roper SVP, CFO 22 Maret 2017 S 8.452 0 0 $0
Steven J Kemper Chief Financial Officer 15 Mei 2007 A 26.255 0 0 $0
Quentin S. Blackford Chief Operating Officer 10 Sep. 2021 S 19.280 0 0 $0
Michael Jon Brown EVP Chief Legal Compliance Off 15 Okt. 2026 S 98.185 0 8 $-1.018.674
Sadie Stern EVP Chief People & Culture Off 28 Sep. 2026 S 123.478 0 2 $-447.644
Jereme M Sylvain EVP, Chief Financal Officer 10 Sep. 2026 S 146.828 0 1 $-302.936
Kevin R Sayer Executive Chair 20 Agu 2026 S 302.214 0 6 $-8.303.410
Jon Coleman EVP, Chief Commercial Officer 4 Juni 2026 S 95.450 0 2 $-722.628
Matthew Vincent Dolan EVP, Strategy & Corporate Dev 29 Jan. 2025 S 42.044 0 0 $0
Teri L Lawver EVP Chief Commercial Officer 12 Maret 2024 S 66.641 0 0 $0
Paul R Flynn EVP Global Revenue 18 Des. 2023 D 48.949 0 0 $0
Barry J. Regan EVP Operations 18 Des. 2023 D 58.469 0 0 $0
Steven Robert Pacelli EVP Managing Director Dexcom V 24 Nov. 2023 S 124.775 0 0 $0
Girish Naganathan EVP Chief Technology Officer 9 Nov. 2023 S 47.725 0 0 $0
Shelly Ramasamy Selvaraj SVP Chief Information Officer 11 Sep. 2023 D 48.453 0 0 $0
Donald Abbey EVP Global Business Services I 10 Maret 2023 D 208.023 0 0 $0
Andrew K Balo EVP Regulatory Strategy Clinic 10 Maret 2023 D 50.908 0 0 $0
Chad Patterson EVP Global Marketing 9 Mei 2022 S 13.675 0 0 $0
Sumi Shrishrimal SVP Chief Risk Officer 9 Maret 2022 D 13.789 0 0 $0
Patrick Michael Murphy EVP, Chief Legal Officer 9 Sep. 2021 S 16.254 0 0 $0
Richard Doubleday EVP Chief Commercial Officer 23 Maret 2021 S 6.654 0 0 $0
Jeffrey Moy EVP Operations 9 Sep. 2020 D 34.784 0 0 $0
Heather S Ace SVP Human Resources 11 Maret 2020 S 38.584 0 0 $0
Terrance H Gregg Executive Chairman 16 Juli 2018 S 50.882 0 0 $0
John Lister General Manager, EMEA 9 Maret 2017 M 84.034 0 0 $0
Peter Gerhardsson VP, Int'l Bus. Dev. 16 Nov. 2010 P 3.387 0 0 $0
David Carner VP, Quality Assurance 16 Agu 2010 A · 0 0 $0
Laura Johnson V.P., Intellectual Property 12 Maret 2010 A · 0 0 $0
Richard Yang V.P., Strategic Affairs 12 Maret 2010 A · 0 0 $0
Claudia Graham VP Marketing 12 Maret 2010 A 18.741 0 0 $0
Rodney L Kellogg Vice President of Sales 19 Mei 2008 A · 0 0 $0
James H Brauker VP Research & Development 24 Maret 2008 A 53.125 0 0 $0
Mark Brister VP, Advanced Development Team 2 Nov. 2007 A 10.967 0 0 $0
John Riolo VP of Quality Assurance 2 Agu 2007 A · 0 0 $0
Tae Andrews Vice President of Marketing 9 Maret 2007 A · 0 0 $0
Nicholas Augustinos Direktur 15 Sep. 2026 S 29.293 0 2 $-679.769
Glenn S Boehnlein Direktur 10 Sep. 2026 A 5.841 0 0 $0
Bridgette P Heller Direktur 12 Agu 2026 S 29.570 0 4 $-277.672
Mark G Foletta Direktur 3 Agu 2026 S 48.852 0 4 $-627.183
Albert Frederick Osterloh IV Direktur 28 Mei 2026 A 8.691 0 0 $0
Euan A. Ashley Direktur 28 Mei 2026 A 12.731 0 0 $0
Rimma Driscoll Direktur 28 Mei 2026 A 17.319 0 0 $0
Kyle Malady Direktur 28 Mei 2026 A 28.242 0 0 $0
Richard Alexander Collins Direktur 28 Mei 2026 A 5.605 0 2 $-389.410
Renee D Gala Direktur 28 Mei 2026 A 12.486 0 0 $0
Steven R Altman Direktur 28 Mei 2026 A 5.565 0 0 $0
Karen M Dahut Direktur 8 Mei 2025 G 17.779 0 0 $0
Eric Topol Direktur 8 Mei 2025 G 380.545 0 0 $0
Barbara Kahn Direktur 18 Mei 2024 G 22.575 0 0 $0
Jay S Skyler Direktur 18 Mei 2023 G 63.348 0 0 $0
Jonathan T Lord MD Direktur 1 Sep. 2016 S 52.820 0 0 $0
Martin Doordan Direktur 1 Juni 2012 A 39.633 0 0 $0
Donald A Lucas Direktur 19 Mei 2010 A 16.448 0 0 $0
Donald L Lucas Direktur 15 Maret 2010 S 69.076 0 0 $0
Sean Carney Direktur 19 Mei 2008 A 20.285 0 0 $0
Glen D Nelson Direktur 14 Maret 2008 P 170.654 0 0 $0
Kim D Blickenstaff Direktur 23 Mei 2007 A 4.104 0 0 $0
Brenton Karl Ahrens Direktur 13 April 2006 A 280.619 0 0 $0
Jorge A Valdes · 13 Maret 2017 S 10.442 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 166 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
IHI · iShares Trust 4,91% 1.844.741 SH 11 Sep. 2026 Harian
GDOC · Goldman Sachs ETF Trust 3,86% 8.317 NS 31 Agu 2026 N-PORT
JMID · Janus Detroit Street Trust 2,74% 7.762 NS 31 Juli 2026 N-PORT
FGSI · First Trust Exchange-Traded Fund IV 2,12% 527 NS 31 Juli 2026 N-PORT
QQQG · Pacer Funds Trust 2,04% 4.976 NS 31 Juli 2026 N-PORT
ABOT · Abacus FCF ETF Trust 1,96% 948 NS 31 Juli 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,44% 178.499 SH 28 Okt. 2026 Harian
SPGP · Invesco Exchange-Traded Fund Trust 1,40% 370.873 SH 28 Okt. 2026 Harian
AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… 1,28% 17.329 NS 31 Juli 2026 N-PORT
COWG · Pacer Funds Trust 1,15% 305.526 NS 31 Juli 2026 N-PORT
QQQE · Direxion Shares ETF Trust 1,15% 184.331 NS 31 Juli 2026 N-PORT
MMID · MFS Active Exchange Traded Funds Tr… 1,06% 4.208 NS 31 Agu 2026 N-PORT
FWD · AB Active ETFs, Inc. 1,03% 362.927 NS 31 Agu 2026 N-PORT
RILA · Spinnaker ETF Series 1,01% 5.118 NS 31 Juli 2026 N-PORT
BRCE · MFS Active Exchange Traded Funds Tr… 0,99% 4.006 NS 31 Agu 2026 N-PORT
IWP · iShares Trust 0,95% 2.162.676 SH 11 Sep. 2026 Harian
QFLR · Innovator ETFs Trust 0,93% 58.151 NS 31 Juli 2026 N-PORT
PALC · Pacer Funds Trust 0,81% 20.420 NS 31 Juli 2026 N-PORT
MEDI · Harbor ETF Trust 0,81% 3.979 NS 31 Juli 2026 N-PORT
FMED · Fidelity Covington Trust 0,71% 4.000 NS 31 Agu 2026 N-PORT
QNXT · iShares Trust 0,62% 2.014 SH 11 Sep. 2026 Harian
SDG · iShares Trust 0,60% 11.793 SH 11 Sep. 2026 Harian
VOT · VANGUARD INDEX FUNDS 0,57% 2.956.203 SH 19 Agu 2026 Harian
QIDX · Spinnaker ETF Series 0,55% 2.575 NS 31 Juli 2026 N-PORT
PDP · Invesco Exchange-Traded Fund Trust 0,53% 96.404 SH 28 Okt. 2026 Harian
FXH · First Trust Exchange-Traded AlphaDE… 0,52% 65.774 NS 31 Juli 2026 N-PORT
IYH · iShares Trust 0,52% 224.542 SH 11 Sep. 2026 Harian
COWZ · Pacer Funds Trust 0,49% 1.097.680 NS 31 Juli 2026 N-PORT
FTC · First Trust Exchange-Traded AlphaDE… 0,48% 76.326 NS 31 Juli 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,46% 183.141 NS 31 Juli 2026 N-PORT
IMCG · iShares Trust 0,45% 213.189 SH 11 Sep. 2026 Harian
SPHQ · Invesco Exchange-Traded Fund Trust 0,44% 1.049.103 SH 28 Okt. 2026 Harian
IXJ · iShares Trust 0,41% 203.560 SH 11 Sep. 2026 Harian
VHT · VANGUARD WORLD FUND 0,38% 1.156.710 SH 19 Agu 2026 Harian
CURE · Direxion Shares ETF Trust 0,37% 7.593 NS 31 Juli 2026 N-PORT
VFQY · VANGUARD WELLINGTON FUND 0,34% 23.742 SH 19 Agu 2026 Harian
MMLG · First Trust Exchange-Traded Fund VI… 0,33% 3.387 NS 31 Agu 2026 N-PORT
GINN · Goldman Sachs ETF Trust 0,32% 6.928 NS 31 Agu 2026 N-PORT
FNDA · SCHWAB STRATEGIC TRUST 0,29% 287.839 NS 31 Agu 2026 N-PORT
RECS · Columbia ETF Trust I 0,27% 187.634 NS 31 Juli 2026 N-PORT
VO · VANGUARD INDEX FUNDS 0,25% 8.362.213 SH 19 Agu 2026 Harian
SIZE · iShares Trust 0,24% 12.297 SH 11 Sep. 2026 Harian
FAD · First Trust Exchange-Traded AlphaDE… 0,24% 16.587 NS 31 Juli 2026 N-PORT
IWR · iShares Trust 0,24% 1.572.597 SH 11 Sep. 2026 Harian
IMCB · iShares Trust 0,23% 45.160 SH 11 Sep. 2026 Harian
ESUM · Strategy Shares 0,23% 4.954 NS 31 Juli 2026 N-PORT
GSEW · Goldman Sachs ETF Trust 0,22% 50.113 NS 31 Agu 2026 N-PORT
ESLG · Strategy Shares 0,20% 561 NS 31 Juli 2026 N-PORT
EUSA · iShares, Inc. 0,19% 43.412 SH 11 Sep. 2026 Harian
JQUA · J.P. Morgan Exchange-Traded Fund Tr… 0,18% 181.851 NS 31 Juli 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0,18% 2.342.132 SH 28 Okt. 2026 Harian
XOEF · iShares Trust 0,18% 485 SH 11 Sep. 2026 Harian
LRND · New York Life Investments ETF Trust 0,18% 8.712 NS 31 Juli 2026 N-PORT
USNZ · DBX ETF Trust 0,16% 5.394 NS 31 Agu 2026 N-PORT
CATH · Global X Funds 0,15% 23.840 NS 31 Juli 2026 N-PORT
QYLG · Global X Funds 0,15% 2.837 NS 31 Juli 2026 N-PORT
PTNQ · Pacer Funds Trust 0,15% 21.359 NS 31 Juli 2026 N-PORT
QTR · Global X Funds 0,15% 136 NS 31 Juli 2026 N-PORT
QQWZ · Pacer Funds Trust 0,15% 895 NS 31 Juli 2026 N-PORT
QYLD · Global X Funds 0,15% 141.287 NS 31 Juli 2026 N-PORT
QCLR · Global X Funds 0,14% 57 NS 31 Juli 2026 N-PORT
QRMI · Global X Funds 0,14% 246 NS 31 Juli 2026 N-PORT
SNPG · DBX ETF Trust 0,14% 221 NS 31 Agu 2026 N-PORT
QSIX · Pacer Funds Trust 0,14% 298 NS 31 Juli 2026 N-PORT
SCHG · SCHWAB STRATEGIC TRUST 0,14% 935.721 NS 31 Agu 2026 N-PORT
USXF · iShares Trust 0,13% 22.924 SH 11 Sep. 2026 Harian
QQQ · Invesco QQQ Trust, Series 1 0,13% 7.821.998 SH 28 Okt. 2026 Harian
QQQM · Invesco Exchange-Traded Fund Trust … 0,13% 1.788.289 SH 28 Okt. 2026 Harian
GGUS · Goldman Sachs ETF Trust 0,12% 6.431 NS 31 Agu 2026 N-PORT
QUAL · iShares Trust 0,12% 666.753 SH 11 Sep. 2026 Harian
FEX · First Trust Exchange-Traded AlphaDE… 0,11% 20.921 NS 31 Juli 2026 N-PORT
GARP · iShares Trust 0,11% 40.229 SH 11 Sep. 2026 Harian
MNZL · EA Series Trust 0,11% 336 NS 31 Juli 2026 N-PORT
DXUV · Dimensional ETF Trust 0,11% 7.089 NS 31 Juli 2026 N-PORT
INFO · Harbor ETF Trust 0,11% 10.730 NS 31 Juli 2026 N-PORT
ILCG · iShares Trust 0,10% 37.554 SH 11 Sep. 2026 Harian
AQLT · iShares Trust 0,10% 3.937 SH 11 Sep. 2026 Harian
IQSU · New York Life Investments ETF Trust 0,10% 3.878 NS 31 Juli 2026 N-PORT
IWF · iShares Trust 0,10% 1.441.625 SH 11 Sep. 2026 Harian
CHRI · Global X Funds 0,10% 93 NS 31 Juli 2026 N-PORT
SPUS · Tidal Trust I 0,09% 32.406 NS 31 Agu 2026 N-PORT
OMFL · Invesco Exchange-Traded Self-Indexe… 0,09% 55.988 SH 28 Okt. 2026 Harian
DSI · iShares Trust 0,09% 58.749 SH 11 Sep. 2026 Harian
VUG · VANGUARD INDEX FUNDS 0,09% 4.943.048 SH 19 Agu 2026 Harian
QARP · DBX ETF Trust 0,09% 763 NS 31 Agu 2026 N-PORT
DFAC · Dimensional ETF Trust 0,09% 499.383 NS 31 Juli 2026 N-PORT
DFSU · Dimensional ETF Trust 0,09% 23.598 NS 31 Juli 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0,09% 8.945 SH 28 Okt. 2026 Harian
VONG · VANGUARD SCOTTSDALE FUNDS 0,08% 603.971 SH 19 Agu 2026 Harian
WRND · New York Life Investments ETF Trust 0,08% 100 NS 31 Juli 2026 N-PORT
SPXD · DBX ETF Trust 0,08% 61 NS 31 Agu 2026 N-PORT
DCOR · Dimensional ETF Trust 0,08% 31.150 NS 31 Juli 2026 N-PORT
GLOV · Goldman Sachs ETF Trust 0,08% 15.096 NS 31 Agu 2026 N-PORT
EGLE · Global X Funds 0,08% 20 NS 31 Juli 2026 N-PORT
GLBL · Pacer Funds Trust 0,08% 10 NS 31 Juli 2026 N-PORT
ONEQ · Fidelity Commonwealth Trust 0,07% 88.313 NS 31 Agu 2026 N-PORT
GSLC · Goldman Sachs ETF Trust 0,06% 103.133 NS 31 Agu 2026 N-PORT
TOPC · iShares Trust 0,06% 230 SH 11 Sep. 2026 Harian
JUST · Goldman Sachs ETF Trust 0,06% 3.611 NS 31 Agu 2026 N-PORT
QVML · Invesco Exchange-Traded Fund Trust … 0,06% 12.306 SH 28 Okt. 2026 Harian
XVV · iShares Trust 0,06% 4.446 SH 11 Sep. 2026 Harian
XRMI · Global X Funds 0,06% 333 NS 31 Juli 2026 N-PORT
XTR · Global X Funds 0,06% 32 NS 31 Juli 2026 N-PORT
GSUS · Goldman Sachs ETF Trust 0,06% 20.252 NS 31 Agu 2026 N-PORT
XCLR · Global X Funds 0,05% 23 NS 31 Juli 2026 N-PORT
IVE · iShares Trust 0,05% 312.923 SH 11 Sep. 2026 Harian
XYLG · Global X Funds 0,05% 394 NS 31 Juli 2026 N-PORT
XYLD · Global X Funds 0,05% 19.868 NS 31 Juli 2026 N-PORT
IUSV · iShares Trust 0,05% 165.780 SH 11 Sep. 2026 Harian
SCHX · SCHWAB STRATEGIC TRUST 0,05% 413.472 NS 31 Agu 2026 N-PORT
DEUS · DBX ETF Trust 0,05% 1.668 NS 31 Agu 2026 N-PORT
XMAG · Tidal Trust II 0,05% 1.018 NS 31 Agu 2026 N-PORT
TOV · EA Series Trust 0,05% 1.441 NS 31 Juli 2026 N-PORT
ACVF · ETF Opportunities Trust 0,05% 912 NS 31 Juli 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0,05% 32.725 NS 31 Juli 2026 N-PORT
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,05% 53.113 NS 31 Juli 2026 N-PORT
PTLC · Pacer Funds Trust 0,05% 19.478 NS 31 Juli 2026 N-PORT
IVV · iShares Trust 0,05% 4.868.303 SH 11 Sep. 2026 Harian
DFVX · Dimensional ETF Trust 0,05% 3.126 NS 31 Juli 2026 N-PORT
VOTE · TCW ETF Trust 0,05% 6.516 NS 31 Juli 2026 N-PORT
ILCB · iShares Trust 0,05% 7.544 SH 11 Sep. 2026 Harian
SCHK · SCHWAB STRATEGIC TRUST 0,05% 31.762 NS 31 Agu 2026 N-PORT
GUSA · Goldman Sachs ETF Trust II 0,05% 12.992 NS 31 Agu 2026 N-PORT
DFUS · Dimensional ETF Trust 0,05% 120.564 NS 31 Juli 2026 N-PORT
VOXP · Advisors Series Trust 0,05% 33 NS 31 Juli 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,05% 230.603 NS 31 Agu 2026 N-PORT
IVW · iShares Trust 0,05% 421.263 SH 11 Sep. 2026 Harian
IYY · iShares Trust 0,05% 16.523 SH 11 Sep. 2026 Harian
IWB · iShares Trust 0,05% 264.795 SH 11 Sep. 2026 Harian
SPUU · Direxion Shares ETF Trust 0,05% 1.456 NS 31 Juli 2026 N-PORT
PBUS · Invesco Exchange-Traded Fund Trust … 0,05% 62.327 SH 28 Okt. 2026 Harian
APUE · Trust for Professional Managers 0,05% 12.441 NS 31 Agu 2026 N-PORT
QDPL · Pacer Funds Trust 0,05% 9.285 NS 31 Juli 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,05% 2.263 SH 28 Okt. 2026 Harian
DFAU · Dimensional ETF Trust 0,05% 67.183 NS 31 Juli 2026 N-PORT
IUSG · iShares Trust 0,04% 173.802 SH 11 Sep. 2026 Harian
ITOT · iShares Trust 0,04% 499.542 SH 11 Sep. 2026 Harian
IWV · iShares Trust 0,04% 104.639 SH 11 Sep. 2026 Harian
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 5.410 SH 28 Okt. 2026 Harian
SFY · Tidal Trust I 0,04% 3.101 NS 31 Agu 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,04% 10.024.256 SH 19 Agu 2026 Harian
VV · VANGUARD INDEX FUNDS 0,04% 450.660 SH 19 Agu 2026 Harian
VTI · VANGUARD INDEX FUNDS 0,04% 12.252.641 SH 19 Agu 2026 Harian
VOOG · VANGUARD ADMIRAL FUNDS 0,04% 146.079 SH 19 Agu 2026 Harian
VOOV · VANGUARD ADMIRAL FUNDS 0,04% 43.354 SH 19 Agu 2026 Harian
VONE · VANGUARD SCOTTSDALE FUNDS 0,04% 63.234 SH 19 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,04% 32.310 SH 19 Agu 2026 Harian
ESGV · VANGUARD WORLD FUND 0,04% 86.728 SH 19 Agu 2026 Harian
HCMT · Direxion Shares ETF Trust 0,04% 2.682 NS 31 Juli 2026 N-PORT
KOKU · DBX ETF Trust 0,04% 3.522 NS 31 Agu 2026 N-PORT
TOK · iShares Trust 0,04% 1.068 SH 11 Sep. 2026 Harian
PHDG · Invesco Actively Managed Exchange-T… 0,04% 297 SH 28 Okt. 2026 Harian
SPXL · Direxion Shares ETF Trust 0,04% 30.165 NS 31 Juli 2026 N-PORT
URTH · iShares, Inc. 0,04% 34.971 SH 11 Sep. 2026 Harian
TILT · FlexShares Trust 0,03% 8.908 NS 31 Juli 2026 N-PORT
ACWI · iShares Trust 0,03% 121.058 SH 11 Sep. 2026 Harian
RWL · Invesco Exchange-Traded Fund Trust … 0,02% 30.037 SH 28 Okt. 2026 Harian
PRF · Invesco Exchange-Traded Fund Trust 0,02% 28.900 SH 28 Okt. 2026 Harian
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,02% 323.858 SH 19 Agu 2026 Harian
FNDB · SCHWAB STRATEGIC TRUST 0,02% 3.070 NS 31 Agu 2026 N-PORT
DYNF · BlackRock ETF Trust 0,02% 87.332 SH 11 Sep. 2026 Harian
USCA · DBX ETF Trust 0,02% 6.538 NS 31 Agu 2026 N-PORT
USCL · iShares Trust 0,02% 5.063 SH 11 Sep. 2026 Harian
LGDX · Tidal Trust III 0,01% 229 NS 31 Juli 2026 N-PORT
CRBN · iShares Trust 0,01% 1.408 SH 11 Sep. 2026 Harian
PEVC · Pacer Funds Trust 0,00% 1 NS 31 Juli 2026 N-PORT

DXCM Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21
peringkat · 35 analis BELI
Target median $95.00 +20,8%
15 42,9% Beli Kuat
15 42,9% Beli
5 14,3% Tahan
0 0,0% Jual
0 0,0% Jual Kuat

Target Harga 12 Bulan

26 analis · 2026-10-23

Target rata-rata $96.46 +22,7%

← Di bawah semua target Harga saat ini $78.62
Rendah$79.00 Rata-rata$96.46 Tinggi$115.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
DXCM $25.54B 31.8 15.6% 17.9% 31.4% 60.1%
EW $49.50B 46.6 11.6% 17.7% 10.6% 78.0%
BDX · 25.3 8.2% 7.7% 6.5% ·
IDXX $53.93B 51.7 10.4% 24.6% 69.2% 61.8%
RMD $28.11B 18.7 9.8% 26.9% 23.6% 61.1%
GEHC · 18.0 4.8% 10.1% 22.1% 40.0%
ZBH $28.66B 25.3 7.2% 8.6% 5.6% ·
GKOS $6.49B -34.4 32.3% -37.0% -26.4% 55.7%
BAX $13.05B -10.2 5.7% -8.5% -14.6% 30.0%
PEN $12.20B 68.8 17.5% 12.7% 13.1% 67.1%
GMED · 22.3 16.7% 18.3% 12.1% ·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23
DexCom (DXCM) Mencatat Kinerja Positif 2026, Naik 6,6% Yahoo Finance · Apakah Analis Wall Street Optimis pada Saham DexCom? Yahoo Finance · DexCom (DXCM) Melaporkan Pendapatan Q1 2026 sebesar $1,19B dengan Pertumbuhan 15% Yahoo Finance ·

Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan

25
BLUECHIP_DIP Stop out Okt 12, 2026
risiko 1 imbalan 1,67
masuk $85.69 R:R 1,67
BLUECHIP_DIP Stop out Apr 20, 2026
risiko 1 imbalan 1,92
masuk $64.82 R:R 1,92
BLUECHIP_DIP Stop out Apr 9, 2026
risiko 1 imbalan 1,85
masuk $65.02 R:R 1,85
RANGE Stop out Mar 27, 2026
risiko 1 imbalan 4,99
masuk $63.32 R:R 4,99

Tidak ada sinyal terbuka saat ini — tidak ada kartu yang terisi, dan itu jujur.

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Sumber: SEC 10-Q diajukan Jul 30, 2026